HUM vs LLY · P/E 39, rev $129.66B vs P/E 39, rev $22.97B
Humana Inc (HUM) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the HUM and LLY stock pages for the full models.
Not investment advice.